Stevanato Group S.p.A STVN
NYSE STVN
$19.95 -1.03 (-4.91%)
As of: Oct 1, 2026 · 3:59 PM EDT

Stevanato Group S.p.A (STVN) EBITDA Margin (2020 - 2026)

Updated

Stevanato Group S.p.A (STVN) recorded EBITDA Margin of 19.91% in the quarter ended Jun 30, 2026, down 1.43 percentage points from 21.34% a year earlier and down 2.06 percentage points from the prior quarter.

Analysis

Stevanato Group S.p.A (STVN) EBITDA Margin (2020 - 2026) Analysis & Trends

On a TTM basis, Stevanato Group S.p.A's EBITDA Margin came in at 23.05% as of Jun 30, 2026, up 1.25 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 23.07%, up 2.57 percentage points from the prior year.

  • Annual EBITDA Margin has a five-year change of +1.25 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, EBITDA Margin came in at 20.50% in the year ended Dec 31, 2024 (-3.76 pp), 24.26% in the year ended Dec 31, 2023 (-0.42 pp), 24.68% in the year ended Dec 31, 2022 (+0.40 pp) and 24.28% in the year ended Dec 31, 2021 (+2.46 pp).
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly EBITDA Margin since the quarter ended Jun 30, 2024.
  • On a year-over-year basis, EBITDA Margin rose in six of the last eight quarters, with an average year-over-year change of +0.77 percentage points.
  • Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 6.19 percentage points in the quarter ended Sep 30, 2022, against a drop of 6.41 percentage points in the quarter ended Jun 30, 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at 21.97% (quarter ended Mar 31, 2026), 26.33% (quarter ended Dec 31, 2025) and 23.42% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 21.86%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 41.08%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 25.55%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 28.17%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 31.93%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 24.62%
10 Stevanato Group S.p.A 6.34 Bn 5.78 Bn 100.91 Mn 19.91%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.91%
Mar 31, 2026 21.97%
Dec 31, 2025 26.33%
Sep 30, 2025 23.42%
Jun 30, 2025 21.34%
Mar 31, 2025 20.17%
Dec 31, 2024 24.99%
Sep 30, 2024 20.04%
Jun 30, 2024 17.30%
Mar 31, 2024 18.26%
Dec 31, 2023 24.89%
Sep 30, 2023 24.98%
Jun 30, 2023 23.71%
Mar 31, 2023 23.16%
Dec 31, 2022 26.17%
Sep 30, 2022 24.69%
Jun 30, 2022 23.97%
Mar 31, 2022 23.41%
Dec 31, 2021 23.72%
Sep 30, 2021 18.49%
API Access

Stevanato Group S.p.A EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=STVN&period=max&api_key=YOUR_API_KEY